Clinical trial
Phase 1 Trial of a Malaria Vaccine in Young Kenyan Children
NCT00317473 · U.S. Army Medical Research and Development Command, U.S. Fed · Completed
Key facts
| NCT number | NCT00317473 |
|---|---|
| Title | Phase 1 Trial of a Malaria Vaccine in Young Kenyan Children |
| Official title | Double-blind,Randomized,Controlled,Dose Escalation Phase 1 Trial in 12-47 Month Old Children in Western Kenya to Evaluate the Safety and Immunogenicity of WRAIR's MSP-1(FMP1) Malaria Vaccine Adjuvanted in GSK's AS02A Versus Rabies Vaccine. |
| Lead sponsor | U.S. Army Medical Research and Development Command, U.S. Fed |
| Collaborators | Kenya Medical Research Institute Walter Reed Army Institute of Research (WRAIR) U.S. Fed The PATH Malaria Vaccine Initiative (MVI) United States Agency for International Development (USAID)… |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Plasmodium Falciparum Malaria |
| Intervention type | Biological |
| Interventions | FMP1/AS02A Malaria vaccine, Imovax Rabies vaccine |
| Enrollment | 135 |
| Start date | Jun 1, 2003 |
| Primary completion | Jul 1, 2004 |
| Completion | Jul 1, 2005 |
| First posted | Apr 24, 2006 |
| Last update posted | Oct 2, 2017 |
| Countries | Kenya |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: